Compile Data Set for Download or QSAR
maximum 50k data
Found 646 of kd for UniProtKB: Q96SW2
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631088((1S)-N-(2,6-Dioxopiperidin-3-yl)-1,2,3,4-tetrahydr...)
Affinity DataKd: <1nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM627126(3-Methoxy-N-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol...)
Affinity DataKd: <1nMAssay Description:1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content2) Titration measur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631094((S)-N-(2,6-Dioxopiperidin-3-yl)benzofuran-3-carbox...)
Affinity DataKd:  1nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631095((N-((R)-2,6-Dioxopiperidin-3-yl)-6,7-dihydro-5H-cy...)
Affinity DataKd: <1nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631102((S)-N-(2,6-Dioxopiperidin-3-yl)-2,3-dihydro-1H-pyr...)
Affinity DataKd: <1nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631105((4S)-N-[(3S)-2,6-Dioxopiperidin-3-yl]-1,2,3,4-tetr...)
Affinity DataKd: <1nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631110(N-[(3S)-2,6-Dioxo-3-piperidyl]-1,2,3,4-tetrahydroq...)
Affinity DataKd: <1nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631116((4S)-N-[(3R)-2,6-Dioxopiperidin-3-yl]-1,2,3,4-tetr...)
Affinity DataKd: <1nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631120((S)-N-(2,6-Dioxopiperidin-3-yl)pyrazolo[1,5-a]pyri...)
Affinity DataKd: <1nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631121((R)-N-(2,6-Dioxopiperidin-3-yl)pyrazolo[1,5-a]pyri...)
Affinity DataKd: <1nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631122((R)-N-(2,6-Dioxopiperidin-3-yl)-1H-indazole-3-carb...)
Affinity DataKd: <1nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631127((S)-N-(2,6-Dioxopiperidin-3-yl)imidazo[1,2-a]pyrid...)
Affinity DataKd:  1nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631128((R)-N-(2,6-Dioxopiperidin-3-yl)imidazo[1,2-a]pyrid...)
Affinity DataKd: <1nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM627006(5-(2-(Quinolin-4-yl)-1H-imidazol-1-yl)-1H-benzo[d]...)
Affinity DataKd:  1nMAssay Description:1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content2) Titration measur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM627018(5-(Indoline-1-carbonyl)-1H-benzo[d]imidazol-2(3H)-...)
Affinity DataKd:  1nMAssay Description:1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content2) Titration measur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM627021(1-Methyl-2-oxo-N-phenyl-3H-imidazo[4,5-b]pyridine-...)
Affinity DataKd:  1nMAssay Description:1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content2) Titration measur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM627024(2-Isopropyl-N-methyl-2′-oxo-2′,3′...)
Affinity DataKd:  1nMAssay Description:1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content2) Titration measur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM627038(1-Methyl-5-phenyl-3H-imidazo[4,5-b]pyridin-2-one |...)
Affinity DataKd: <1nMAssay Description:1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content2) Titration measur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM627049(6-(Indoline-1-carbonyl)-1,3-dihydro-2H-imidazo[4,5...)
Affinity DataKd: <1nMAssay Description:1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content2) Titration measur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM627056(5-(4-Acetylpiperazin-1-yl)-1,3-dihydro-2H-benzo[d]...)
Affinity DataKd: <1nMAssay Description:1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content2) Titration measur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM627064(2-(4-Aminophenyl)-N-(2-oxo-2,3-dihydro-1H-benzo[d]...)
Affinity DataKd:  1nMAssay Description:1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content2) Titration measur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM627088(1-Benzyl-3-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-...)
Affinity DataKd: <1nMAssay Description:1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content2) Titration measur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM627100(2-(4-(N-Methylsulfamoyl)phenyl)-N-(2-oxo-2,3-dihyd...)
Affinity DataKd:  1nMAssay Description:1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content2) Titration measur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631092(N-((S)-2,6-Dioxopiperidin-3-yl)-6,7-dihydro-5H-cyc...)
Affinity DataKd:  1nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631082(N-(2,6-Dioxopiperidin-3-yl)indoline-1-carboxamide ...)
Affinity DataKd:  2nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631085(N-(2,6-dioxo-3-piperidyl)benzofuran-3-carboxamide ...)
Affinity DataKd:  2nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM600503(US11623929, Example 5 | methyl 6-(2,4-dioxo-1,3,7-...)
Affinity DataKd:  2nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM627050(N-(1-Acetylpiperidin-4-yl)-2-oxo-2,3-dihydro-1H-im...)
Affinity DataKd:  2nMAssay Description:1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content2) Titration measur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM627068(4-Acetamido-N-(2-oxo-2,3-dihydro-1H-benzo[d]imidaz...)
Affinity DataKd:  2nMAssay Description:1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content2) Titration measur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631126((R)-N-(2,6-Dioxopiperidin-3-yl)indolizine-3-carbox...)
Affinity DataKd:  2nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631089(N-(2,6-Dioxopiperidin-3-yl)-N-methyl-1H-indole-3-c...)
Affinity DataKd:  3nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631093(N-((R)-2,6-Dioxopiperidin-3-yl)-6,7-dihydro-5H-cyc...)
Affinity DataKd:  3nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631100((S)-N-((S)-2,6-Dioxopiperidin-3-yl)-1,2,3,4-tetrah...)
Affinity DataKd:  3nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631124((R)-N-(2,6-Dioxopiperidin-3-yl)imidazo[1,5-a]pyrid...)
Affinity DataKd:  3nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631140((R)-2-(3-Acetamidophenyl)-N-(2,6-dioxopiperidin-3-...)
Affinity DataKd:  3nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631143((R)-N-(2,6-Dioxopiperidin-3-yl)-2-(2-oxoindolin-5-...)
Affinity DataKd:  3nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM600500(7-((S)-1,2,3,4- tetrahydronaphthalene-1-carbonyl)-...)
Affinity DataKd:  3nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM627076(Methyl 1-(2-oxo-1,3-dihydrobenzimidazol-5-yl)benzi...)
Affinity DataKd:  3nMAssay Description:1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content2) Titration measur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM627077(5-(Benzimidazol-1-yl)-1,3-dihydrobenzimidazol-2-on...)
Affinity DataKd:  3nMAssay Description:1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content2) Titration measur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM627078(5-[2-(1-Hydroxyethyl)benzimidazol-1-yl]-1,3-dihydr...)
Affinity DataKd:  3nMAssay Description:1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content2) Titration measur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM627079(5-[2-[Hydroxy(phenyl)methyl]benzimidazol-1-yl]-1,3...)
Affinity DataKd:  3nMAssay Description:1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content2) Titration measur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM627144(N-(1-((2-Oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)...)
Affinity DataKd:  3nMAssay Description:1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content2) Titration measur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM627017(N-(1-Acetylpiperidin-4-yl)-2-oxo-2,3-dihydro-1H-be...)
Affinity DataKd:  3nMAssay Description:1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content2) Titration measur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631087((1R)-N-(2,6-Dioxopiperidin-3-yl)-1,2,3,4-tetrahydr...)
Affinity DataKd:  4nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631101((S)-N-(2,6-Dioxopiperidin-3-yl)-3,4-dihydroquinoli...)
Affinity DataKd:  4nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631103((S)-N-(2,6-Dioxopiperidin-3-yl)-3,4-dihydro-1,8-na...)
Affinity DataKd:  4nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631118((1R)-N-[(3R)-2,6-Dioxopiperidin-3-yl]-1,2,3,4-tetr...)
Affinity DataKd:  4nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM631123((S)-N-(2,6-Dioxopiperidin-3-yl)imidazo[1,5-a]pyrid...)
Affinity DataKd:  4nMAssay Description:Determination of the affinities of compounds to protein containing one or more tryptophan is measurable by monitoring the fluorescence emission in di...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM600499(7-benzoyl-1,3,7- triazaspiro[4.4]nonane-2,4-dione ...)
Affinity DataKd:  4nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA damage-binding protein 1/Protein cereblon(Homo sapiens (Human))
C4 Therapeutics

US Patent
LigandPNGBDBM627073(2-Isopropyl-N-methyl-1-(2-oxo-1,3-dihydroimidazo[4...)
Affinity DataKd:  4nMAssay Description:1) Optimization of measurement parameters to minimize protein consumption and to minimize the dilution effect and the DMSO content2) Titration measur...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 646 total ) | Next | Last >>
Jump to: